Report #2829838

Received Mar 6, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: OH
Recovered: Unknown
Vaccinated: Sep 24, 2024
Onset: Sep 24, 2024
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (HEPLISAV-B)	DYNAVAX TECHNOLOGIES CORPORATION	1	944917	IM / LA

Symptoms (1)

Incomplete course of vaccination

Symptom narrative

The 2nd Dose of HEPLISAV-B was Confirmed to be Missed; Initial report received on 20-Feb-2025. A pharmacist reported that a 43-year-old male (race, ethnicity not provided) received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization but has not received the second dose yet. No medical history or concomitant vaccines were reported. On 24-Sep-2024, the patient received dose 1 of a hepatitis B vaccine [HEPLISAV-B (lot # 43528-003-05, expiration date 16-Nov-2026, NDC # 43528-003-05)] intramuscularly in the left arm. At the time of the report, the patient has not received the second dose. It was confirmed to be missed. Additional information was not provided. Company Comment: ? The company assessed the event as non-serious.; Sender's Comments: ? The company assessed the event as non-serious.